Schedule 13G ownership disclosure

Cogent Biosciences, Inc.

Security class unavailable · CUSIP: 19240Q102

Event date: 2020-11-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,907,971
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-20-000653
Form type
SC 13G/A
Filer
Cogent Biosciences, Inc.
CIK
CIK 1622229
Filed
Nov 19, 2020
Reporting period
Nov 09, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub